FDA May Amend Liver Damage Warnings For Acetaminophen

Law360, New York (July 3, 2012, 4:17 PM EDT) -- The U.S. Food and Drug Administration will issue guidance to drug manufacturers Thursday on changes it may make to clarify the liver damage warnings that are required on products that include acetaminophen.

In draft guidance to be published in the Federal Register Thursday, the FDA announces it will take action to address possible confusion that can be caused by the wording in the text required on the packaging of drugs containing acetaminophen, which includes a number of bulleted warnings spelling out the circumstances in which acetaminophen...
To view the full article, register now.